[Cesium teletherapy of malignant tumors in the head-neck region. Indications and preliminary results].
D000236:Adenoma / Q000532:radiotherapy; D000368:Aged; D001932:Brain Neoplasms / Q000532:radiotherapy; D002277:Carcinoma / Q000532:radiotherapy; D002291:Carcinoma, Papillary / Q000532:radiotherapy; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D002587:Cesium Isotopes / Q000627:therapeutic use*; D005153:Facial Neoplasms / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006257:Head; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006689:Hodgkin Disease / Q000532:radiotherapy; D006801:Humans; D007822:Laryngeal Neoplasms / Q000532:radiotherapy; D008198:Lymph Nodes; D016403:Lymphoma, Large B-Cell, Diffuse / Q000532:radiotherapy; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy; D008297:Male; D009369:Neoplasms / Q000532:radiotherapy*; D009918:Orbital Neoplasms / Q000532:radiotherapy; D010157:Palatal Neoplasms / Q000532:radiotherapy; D010255:Paranasal Sinus Neoplasms / Q000532:radiotherapy; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy; D011867:Radioisotope Teletherapy; D011879:Radiotherapy Dosage; D013964:Thyroid Neoplasms / Q000532:radiotherapy
D002587:Cesium Isotopes
Die Caesium-Teletherapie maligner Tumoren im Kopf-Hals-Bereich. Indikationen und vorläufige Ergebnisse.